Fertility and Sterility
Volume 93, Issue 1 , Pages 283-285 , 1 January 2010

Outcomes of conservative therapy for young women with early endometrial adenocarcinoma

  • Yuyan Mao, Ph.D.
    • ,
  • Xiaoyun Wan, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Xiaoyun Wan, Master, Women's Hospital, School of Medicine, Zhejiang University, Xueshi Road #2, Hangzhou 310006, P.R. China (FAX: 86-571-87061878).
    • ,
  • Yaxia Chen, Ph.D.
    • ,
  • Weiguo Lv, Ph.D.
    • ,
  • Xing Xie, Master

Received 22 January 2009 ,Revised 8 July 2009 ,Accepted 15 July 2009.

References 

  1. Soliman PT, Oh JG, Schmeler KM, Suu CC, Slomovitz BM, Gershenson DM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105:575–580
  2. Wang CB, Wang CJ, Huang HJ, Hsueh S, Chou HH, Soonq YK, et al. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer. 2002;94:2192–2198
  3. Kempson RL, Polorny GE. Adenocarcinoma of the endometrium in women aged forty and younger. Cancer. 1968;21:650–662
  4. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progesterone alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review of the literature. Cancer. 1997;79:320–327
  5. Randall TC, Kurman RJ. Progesterone treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol. 1997;90:434–440
  6. Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF. Endometrial cancer in women 40 years old or younger. Gynecol Oncol. 2001;83:388–393
  7. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus: usefulness and limitations. Eur J Gynaecol Oncol. 2001;22:217–220
  8. Kaku T, Yoshikawa H, Tsuda H, Sakamoto A, Fukunaga M, Kuwabara Y, et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett. 2001;167:39–48
  9. Niwa K, Tagami K, Lian Z, Onogi K, Mori H, Tamaya T. Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG. 2005;112:317–320
  10. Gotlieb WH, Beiner ME, Shalmon B, Korach Y, Segal Y, Zmira N, et al. Outcome of frtility-sparing treatment with progesterones in young patients with endometrial.
  11. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hornomal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95:133–138
  12. Yahata T, Fujita K, Aoke Y, Tanaka K. Long-term conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod. 2006;21:1070–1075

 X.M. has nothing to disclose. X.W. has nothing to disclose. X.C. has nothing to disclose. X.L. has nothing to disclose. X.X. has nothing to disclose.

PII: S0015-0282(09)02495-9

doi: 10.1016/j.fertnstert.2009.07.999

Fertility and Sterility
Volume 93, Issue 1 , Pages 283-285 , 1 January 2010

Article Tools